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Adipocyte differentiation requires the coordinated activi-
ties of several nuclear transcription factors. Recently, mi-
tochondria biogenesis was reported to occur during adi-
pocyte differentiation and following treatment with thia-
zolidinediones in vitro and in vivo. Crif1 is a translational 
factor for mitochondrial DNA (mtDNA) and is important for 
transcription of the mitochondrial oxidative phosphoryla-
tion (OXPHOS) complex. To investigate the role of OXPHOS 
in adipogenesis, we analyzed adipocyte differentiation 
following disruption of Crif1 in vitro and in vivo. The adi-
pose-specific Crif1 knockout mouse had a lower body 
weight and less fat mass than wild-type mice. Furthermore, 
adipocytes were smaller and had a dysplastic morphology 
in the adipose-specific Crif1 knockout mouse. 3T3-L1 adi-
pocytes or adipose-derived stem cells (ADSCs) that lacked 
Crif1 expressed lower levels of mtDNA-encoded OXPHOS 
subunits, and adipocyte differentiation was disrupted. 
Rosiglitazone treatment did not induce adipogenesis or 
mitochondria biogenesis in Crif1 knockout ADSCs. These 
results show that mitochondrial OXPHOS and Crif1 are 
required for rosiglitazone- and hormone-induced adipo-
genesis. 
 
 
INTRODUCTION 
 
White adipocyte differentiation involves a complex and highly 
orchestrated program of gene expression that is driven by syn-
ergistic interactions between transcription factors including the 
peroxisome proliferator activated receptor gamma (PPARγ), 
CCAAT/enhancer family [CCAAT/enhancer binding protein α, β, 
δ (C/EBPα, β, δ)], and sterol regulatory element binding protein-
1c (SREBP-1c) (Farmer, 2006). These transcription factors 
regulate several intracellular pathways, processes, and secre-
tory factors that influence adipogenesis. Understanding the 
processes responsible for adipogenesis is important because 
adipocyte dysfunction occurs in various chronic metabolic dis-
eases. Improving adipocyte function by modulating adipogenic 
processes may help manage such diseases.  
Marked mitochondrial biogenesis occurs during adipocyte dif-
ferentiation (Newton et al., 2011; Wilson-Fritch et al., 2003). 
The concentration of mitochondrial proteins is increased 20-30-
fold in differentiated 3T3-L1 adipocytes in comparison to the 
concentration in preadipocytes (Newton et al., 2011). Treat-
ment with chemical inhibitors of respiratory chain function, such 
as rotenone, suppresses adipogenesis by modulating the ex-
pression of the key transcription factors C/EBPα, PPARγ, and 
SREBP-1c (Lu et al., 2010). The expression of PPARγ coacti-
vator-1 (PGC-1), which is a key regulator of adipogenesis, cor-
relates with mitochondrial biogenesis and adipogenesis (Gao et 
al., 2011). Consequently, mitochondria have been proposed to 
play an important role in adipogenesis programming and the 
progression of metabolic diseases. However, how sequential 
changes in the levels of mitochondrial proteins affect adipocyte 
differentiation and which genes are involved in mitochondrial 
development remain poorly understood.  
Most cellular energy is released by OXPHOS in the electron 
transport chain in the inner mitochondrial membrane. The 
OXPHOS system in the mammalian respiratory chain is com-
posed of at least 89 polypeptides that are encoded by nuclear 
DNA (nDNA) or mitochondria DNA (mtDNA) (Calvo and Mootha, 
2010; Wallace, 2007). The human mtDNA genome encodes 
only 13 OXPHOS proteins, but these proteins provide an es-
sential framework for the assembly of OXPHOS complexes in 
the inner mitochondrial membrane (Shoubridge, 2001). The 
mitochondrial ribosome is responsible for intra-mitochondrial 
synthesis of mtDNA-encoded OXPHOS polypeptides. Deple-
tion of mitochondrial transcription factor A (TFAM) in 3T3-L1 
cells impairs translocation of glucose transporter 4, down-
stream of Akt, while adipogenic gene expression and lipid ac- 
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cumulation are not affected. However, mitochondria-related 
studies involving the knockdown of genes or inactivation of the 
OXPHOS complex have used cultured cell lines and have not 
been performed in vivo. 
To investigate the role of mitochondrial OXPHOS in adipo-
cyte differentiation, we generated adipose-specific Crif1 loss-of-
function transgenic mouse. A primary mitochondrial function, 
which is important for the translation of the 13 subunits that 
constitute the mitochondrial OXPHOS complexes I, III, IV, and 
V in vitro and in vivo, was disrupted in this mouse model. 
 
MATERIALS AND METHODS 
 
Mice 
Floxed Crif1 (Crif1flox/flox) mice were generated as previously 
described (Kwon et al., 2008). Adiponectin-Cre transgenic mice 
(C57BL/6J) were kindly provided by Dr. Evan D. Rosen. Mice 
were bred in our facility and housed at a constant temperature 
(22°C), with 50-60% humidity and a daily 12 h light/12 h dark 
cycle. All experiments were conducted using male mice housed 
in individual cages, and body weights were checked at 4 weeks 
of age. All mouse experiments were performed in the animal 
facility according to institutional guidelines, and the experimen-
tal protocols were approved by the institutional review board of 
the Korean Research Institute of Biotechnology and Bioscience, 
and Chungnam National University. 
 
Histological and morphometric analysis 
White adipose tissue (WAT) was fixed in 10% neutralized for-
malin, washed, and then embedded in paraffin. Paraffin tissue 
sections of 5 μm were deparaffinized, rehydrated, and stained 
with hematoxylin and eosin. For whole-mount fluorescence 
staining, epididymal WAT was fixed in 10% neutralized formalin. 
Formalin was removed with 20% sucrose, and WAT was then 
incubated with an anti-PECAM antibody (Millipore; MAB1398Z) 
and incubated for 10 min at room temperature with DAPI and 
BODIPY. 
 
Cell culture and Oil red O staining 
3T3-L1 preadipocytes were purchased from ATCC. Methyliso-
butylxanthine (IBMX), dexamethasone and insulin were ob-
tained from Sigma-Aldrich. 3T3-L1 cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% bovine calf serum (Gibco BRL). Lipofectamine® 
RNAiMAX reagent (Invitrogen) was used to transfect 3T3-L1 
fibroblasts with Crif1 siRNA (GGA GUG CUC GCU UCC AGG 
AAC UAU U). Cells were cultured for 2 days, after which cells 
were differentiated by culturing in DMEM containing IBMX (0.5 
mM), dexamethasone (1 μM), insulin (10 μg/ml), and 10% fetal 
bovine serum for a further 2 days. This medium was then re-
placed with DMEM containing insulin (10 μg/ml), which was 
exchanged every 2 days (Hemati et al., 1997). ADSCs were 
cultured from the Crif1flox/flox mouse, as previously described 
(Estes et al., 2010). After treatment with null or Cre recombi-
nase adenoviruses, ADSCs were differentiated into adipocytes 
by culturing in M199 medium (Gibco BRL) containing IBMX (0.5 
mM), dexamethasone (1 μM), insulin (10 μg/ml), and rosiglita-
zone (0.5 μM) and 10% fetal bovine serum. Differentiated 3T3-
L1 adipocytes or ADSCs were fixed with 4% paraformaldehyde 
for 30 min at room temperature and then washed with 1x PBS. 
Staining was performed with freshly prepared 0.2% Oil red O 
solution for 30 min followed by three washes with water. For 
quantification, Oil red O was dissolved in 200 μl isopropanol 
and the absorbance at 540 nm was measured by ELISA. 
Crif1-HA adenovirus 
Crif1 DNA was amplified by PCR from mouse genomic DNA 
extracted from C57BL/6 mouse liver, and HA was fused at the 
C-terminal of Crif1. The Crif1-HA adenovirus was generated 
using the pAdEasy system as previously described (He et al., 
1998). 
 
Western blotting 
Western blot analysis was performed using 12% acrylamide 
SDS-PAGE gels. Primary antibodies against OXPHOS com-
plex subunits (ND6, NDUFA9, SDHA, UQCRC2, and ATP5A1) 
were purchased from Invitrogen. An anti-COX4 antibody (#4844), 
an anti-VDAC antibody (#4866) and an anti-PPARγ antibody 
(#2435) were purchased from Cell Signaling. An anti-ND1 anti-
body (sc-65237) and an anti-Crif1 antibody (sc-134882) were 
purchased from Santa Cruz Biotechnology. Secondary antibod-
ies (goat anti-mouse and goat anti-rabbit) were obtained from 
Cell Signaling.  
 
Blue native PAGE (BN-PAGE) 
BN-PAGE and mitochondrial isolation was performed as previ-
ously described (Kim et al., 2012). Mitochondrial isolation was 
performed by suspending pellets of fully differentiated ADSCs 
in buffer B (210 mM mannitol, 70 mM sucrose, 1 mM EGTA, 
and 5 mM HEPES, pH 7.2). The mitochondrial fraction was 
used in the Native PAGE™ Novex® Bis-Tris Gel system (Invi-
trogen) with 0.5% n-dodecyl-β-D-maltoside to determine the 
content of the OXPHOS complex. After electrophoresis, the gel 
was transferred to a PVDF membrane, which was then incu-
bated with an anti-OXPHOS antibody mixture (Invitrogen). 
 
Oxygen consumption rate (OCR) 
OCR was measured using an XF-24 analyzer (Seahorse Bio-
science). ADSCs were plated on an XF-24 plate, treated with 
null or Cre recombinase adenovirus, and incubated in differen-
tiation media. The day before OCR measurement, the sensor 
cartridge was calibrated with calibration buffer (Seahorse Bio-
science) at 37°C. Fully differentiated ADSCs were washed and 
cultured in M199 (Gibco BRL) lacking sodium bicarbonate at 
37°C. OCR was automatically calculated and recorded by the 
sensor cartridge and Seahorse XF-24 software. 
 
Real-time PCR and Northern blot 
Total RNA was isolated using Trizol (Invitrogen), in accordance 
with manufacturer’s instructions. Complementary DNA (cDNA) 
was prepared with M-MLV Reverse Transcriptase and oligo-dT 
primers (Invitrogen). Real-time PCR was performed using 
cDNA, QuantiTect™ SYBR® Green PCR Master Mix (QIAGEN), 
and specific primers. Primer sequences were as follows: 
NDUFA9 F (5′-ACTGT GTTTG GGGCT ACAGG-3′), NDUFA9 
R (5′-GATTG ATGAC CACGT TGCTG-3′), SDHA F (5′-
ACACA GACCT GGTGG AGACC-3′), SDHA R (5′-GCACA 
GTCAG CCTCA TTCAA-3′), UQCRC2 F (5′-ATCAA AAGGG 
GCAAC AACAC-3′), UQCRC2 R (5′-CACTC AGGAA GCCCT 
CTGAC-3′), COX4 F (5′-TTGGC AAGAG AGCCA TTTCT-3′), 
COX4 R (5′-GCCCA CAACT GTCTT CCATT-3′), ATP5A1 F 
(5′-AGGCC TATCC TGGTG ATGTG-3′), ATP5A1 R (5′-CTTCA 
TGGTA CCTGC CACCT-3′), ND1 F (5′-ACGCA AAATC 
TTAGG GTACA-3′), ND1 R (5′-GAGTG ATAGG GTAGG 
TGCAA-3′), ND6 F (5′-CACCC AGCTA CTACC ATCAT-3′), 
ND6 R (5′-ATTGG GGGTG ATTAT AGAGG-3′), COX1 F (5′-
ATTCG AGCAG AATTA GGTCA-3′), COX1 R (5′-CTCCG 
ATTAT TAGTG GGACA-3′), ATP6 F (5′-ACGAA AATCT ATTTG 
CCTCA-3′), ATP6 R (5′-TGGTG TGTGG ATTAG CATTA-3′),  
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Fig. 1. Perturbation of adipose tissue development in Crif1
f/f,adipoq 
mice. (A) Western blot analysis of eWAT probing for Crif1 and the OXPHOS 
complex I subunits NDUFA9 and ND1, which are encoded by nDNA and mtDNA, respectively. The β-actin was used as an internal control. (B) 
Tissue weight of mice (n = 10 for each group; means and s.d.s are shown; *P < 0.05). mWAT, mesenteric WAT; sWAT, subcutaneous WAT; 
BAT, brown adipose tissue. (C) Hematoxylin and eosin staining of eWAT. Magnification, × 200. (D) Distribution of adipocyte sizes in eWAT as 
shown in Fig. 1C. (E) Immunofluorescence image of eWAT stained with BODIPY (green), DAPI (blue) and an anti-PECAM antibody (red). 
Magnification, × 200. 
 
 
 
Crif1 F (5′-GAA CG CTGGG AGAAA ATTCA-3′), Crif1 R (5′-
ATAGT TCCTG GAAGC GAGC A-3′), Ppargamma F (5′-
ATCTT AACTG CCGGA TCCAC-3′), Ppargamma R (5′-
TGGTG ATTTG TCCGT TGTCT-3′), Adiponectin F (5′-TCTCC 
TGTTC CTCTT AATCC TGCC-3′), Adiponectin R (5′-CATCT 
CCTTT CTCTC CCTTC TCTCC -3′), CD36 F (5′-TGCTG 
GAGCT GTTAT TGGTG-3′), CD36 R (5′-TGGGT TTTGC ACATC 
AAAGA-3′), Fasn F (5′-CCCTT GATGA AGAGG GATCA-3′), 
Fasn R (5′-ACTCC ACAGG TGGGA ACAAG-3′), C/ebpa F (5′-
TGGAC AAGAA CAGCA ACGAG-3′), C/ebpa R (5′-TCACT 
GGTCA ACTCC AGCAC-3′), C/ebpb F (5′-CAAGC TGAGC 
GACGA GTACA-3′), C/ebpb R (5′-AGCTG CTCCA CCTTC 
TTCTG-3′), C/ebpd F (5′-ATCGA CTTCA GCGCC TACAT-3′), 
and C/ebpd R (5′-GCTTT GTGGT TGCTG TTGAA-3′). Rela-
tive expressions were calculated using Rotor-Gene™ 6000 real-
time rotary analyzer software (Version 1.7, Corbett Life Sci-
ence). 
 
RESULTS 
 
Knockout of Crif1 in adipocytes perturbs adipose tissue  
development 
The mitochondrial protein Crif1 associates with the large sub-
unit of the mitochondrial ribosome and plays a critical role in the 
intra-mitochondrial production and insertion of 13 OXPHOS 
subunits encoded by mtDNA (Kim et al., 2012). Crif1 is ubiqui-
tously expressed in WAT and brown adipose tissue (BAT) (data 
not shown). To identify the function of Crif1 and mitochondrial 
OXPHOS in adipocytes, we generated adipocyte-specific Crif1 
knockout mice by crossing floxed Crif1 mice (Kwon et al., 2008) 
with adiponectin-Cre transgenic mice. The epididymal WAT 
(eWAT) of Crif1f/f,adipoq mice exhibited marked depletion of Crif1 
and ND1, a mtDNA-encoded OXPHOS complex I subunit, and 
a reduction in the level of NDUFA9, a nDNA-encoded OXPHOS 
complex I subunit (Fig. 1A). Crif1f/f,adipoq mice demonstrated a 
marked decrease in the weight of mesenteric WAT (mWAT), 
subcutaneous WAT (sWAT), and BAT (Fig. 1B). Hematoxylin 
and eosin staining of adipose tissues indicated that the adipo-
cytes of Crif1f/f,adipoq mice were relatively smaller and irregularly 
size in comparison to those of Crif1+/+,adipoq mice (Fig. 1C). Dis-
tribution analysis of adipocyte size showed that the peak fre-
quency was approximately 2.5 × 103 μm2 in Crif1f/f,adipoq mice 
and 15 × 103 μm2 in Crif1+/+,adipoq mice (Fig. 1D). BODIPY stain-
ing was reduced in the eWAT of Crif1f/f,adipoq mice, whereas 
nuclei (DAPI) and endothelial cell (anti-PECAM antibody) stain-
ing was unchanged. This indicates that mitochondrial OXPHOS 
dysfunction in these mice may perturb the development of adi-
pose tissue (Fig. 1E). Collectively, data from the adipocyte-
specific Crif1 knockout mouse suggests that loss of Crif1 dis-
rupts adipose tissue development in vivo.  
 
Mitochondrial biogenesis is critical for adipocyte  
differentiation 
It has been previously reported that mitochondrial biogenesis is 
associated with adipocyte differentiation (Luo et al., 2008; Wilson- 
Fritch et al., 2003). In this study, we studied mitochondrial bio- 
genesis during adipogenesis of 3T3-L1 cells. The mtDNA copy 
number was measured using real-time PCR. The mtDNA copy
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number started to increase on day 1 and peaked at day 3 of 
3T3-L1 adipocyte differentiation (Fig. 2A). To determine whether 
this increase in mtDNA copy number was accompanied by an 
increase in the levels of the OXPHOS complex proteins, West-
ern blotting of various OXPHOS subunits was performed on 
whole cell lysates obtained from 3T3-L1 adipocytes (Fig. 2B). 
The levels of various subunits of OXPHOS complexes I, II, III, 
and IV were induced on the first day of differentiation. The 
OXPHOS complex V subunit, ATP5A1, was expressed at a 
relatively high level in all samples (Fig. 2B).  
BN-PAGE analysis showed that the level of assembled 
OXPHOS complexes increased during adipocyte differentiation 
of 3T3-L1 cells (Fig. 2C). To normalize the expression levels of 
OXPHOS subunits, Western blotting of various OXPHOS sub-
units was performed on mitochondria isolated from differentiat-
ing 3T3-L1 cells. The expression of OXPHOS subunits in these 
isolated mitochondria increased as differentiation progressed. 
Crif1 was expressed in undifferentiated 3T3-L1 cells and its 
expression steadily increased during differentiation (Fig. 2D). 
These data indicate that mitochondrial biogenesis, which corre-
lates with an increase in the mtDNA copy number and in-
creased expression of OXPHOS complex subunits, is linked 
with adipocyte differentiation of 3T3-L1 cells.  
Adipose mitochondria function is suppressed in the insulin 
resistant state and the reversal of insulin resistance by treat-
ment with PPAm  γ agonists, such as rosiglitazone, is associated 
with an increase in adipose mitochondrial biogenesis (Sears et 
al., 2009; Wilson-Fritch et al., 2003; 2004). Treatment with a 
low dose of rosiglitazone over a prolonged period stimulated 
the differentiation of 3T3-L1 cells. mosiglitazone treatment in-
creased the intensity of Oil red O staining, whereas staining 
was reduced when cells were treated with ethidium bromide 
(EtBr), which depletes mtDNA (Fig. 3A). Treatment with rosigli-
tazone promoted differentiation of 3T3-L1 cells and induced 
mmNA expression of Crif1 and Cox1, a subunit of OXPHOS 
complex IV (Fig. 3B). Western blotting revealed that rosiglita-
zone treatment increased the expression of subunits of OXPHOS 
complexes I, II, III, IV, and V, whereas treatment with EtBr did 
not (Fig. 3C). These data indicate that PPAmγ-induced adipo-
genesis is linked with the biogenesis of mitochondrial OXPHOS 
complexes. 
 
Crif1 is induced during adipogenesis and is required for  
the differentiation of adipocytes 
Expression of Crif1 mmNA was induced during the early phase 
of adipogenesis, in a similar manner to OXPHOS complex sub-
units (Figs. 2A and 4A). To explore the functional link between 
mitochondrial OXPHOS function and adipocyte differentiation in 
vitro, we monitored the expression of Crif1 and OXPHOS complex 
subunits in 3T3-L1 fibroblasts stimulated with various differen-
tiation signals. Crif1 expression was increased by treatment 
with insulin and/or dexamethasone (Fig. 4B). Treatment with 
IBMX, dexamethasone and insulin increased the expression of 
the OXPHOS subunits, ND1, and the expression of PPAmgam-
ma, a marker of differentiated adipocytes (Fig. 4B). 
The induction of Crif1 expression with half the dose of dexa-
methasone promoted 3T3-L1 adipocyte differentiation as indi- 
cated by enhanced Oil red O staining and increased expression 
of Ppargamma, adiponectin, Cd36 and fatty acid synthase (Fasn) 
(Figs. 5A and 5B). By contrast, when Crif1 was depleted in 3T3-
Fig. 2. Mitochondrial biogenesis during 3T3-L1
adipocyte differentiation. (A) The relative amount
of mtDNA was analyzed by real-time PCR dur-
ing 3T3-L1 adipocyte differentiation. (n = 4; means
and s.d.s are shown; *P < 0.05). Ctr, control; R,
Rosiglitazone; EtBr, ethidium bromide. (B)
Western blot analysis of OXPHOS subunits
encoded by nDNA (NDUFA9, SDHA, SDHB,
UQCRC2, COX4, and ATP5A1) and mtDNA
(ND6) during 3T3-L1 adipocyte differentiation.
(C) BN-PAGE analysis of assembled OXPHOS
complexes in isolated mitochondria during 3T3-
L1 adipocyte differentiation. (D) Western blot
analysis of Crif1, VDAC and OXPHOS subunits
encoded by nDNA (NDUFA9, SDHA, UQCRC2,
COX4, and ATP5A1) and mtDNA (ND1) in
isolated mitochondria during 3T3-L1 adipocyte
differentiation. 
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L1 cells using siRNA, the protein levels of the NDUFA9 and 
COX4, were decreased (Fig. 5D). The mRNA levels of these 
subunits were unchanged (data not shown). These results sug-
gest that the depletion of Crif1 inhibits lipid accumulation and 
decreases the expression of OXPHOS complexes due to de-
fects in mitochondrial translation (Figs. 5C and 5D). Further-
more, depletion of Crif1 reduced the maximal induction of 
Ppargamma, Cd36, and adiponectin (Fig. 5F), but did not affect 
cell viability (Fig. 5E). These observations indicate that Crif1 
plays a crucial role in adipocyte differentiation by regulating the 
expression of adipogenic genes.  
 
Treatment with rosiglitazone fails to promote adipogenesis  
in Crif1 null ADSCs 
To identify the role of mitochondrial OXPHOS in rosiglitazone-
induced adipogenesis, we studied the ability of rosiglitazone to 
promote adipogenesis in Crif1 null ADSCs. These cells were 
generated by infecting stromal vascular fraction cells isolated 
from Crif1flox/flox mice with an adenovirus expressing Cre recom-
binase. The translation of subunits of OXPHOS complex I 
(NDUFA9), III (UQCRC2) and IV (COX4) was perturbed in Crif1 
null ADSCs (Fig. 6A), and the assembly of the OXPHOS com-
plex was also disrupted (Fig. 6B). The mRNA levels of these 
subunits were unchanged (Fig. 6C). This defect in the assem-
bly of the OXPHOS complex led to decreased oxygen con-
sumption by mitochondria (Fig. 6D).  
Treatment with rosiglitazone failed to promote adipogenesis 
in Crif1 null ADSCs. The defect in mitochondrial OXPHOS in 
Crif1 null ADSCs blocked rosiglitazone-induced lipid accumula-
tion (Fig. 7A). As adipogenesis is controlled by the coordinated 
activities of many transcription factors, we monitored the ex-
pression levels of some of these transcription factors in ADSCs 
on days 1, 3, and 7 of the differentiation time course. The ex-
pression levels of C/ebpβ and C/ebpδ, which are involved in 
3T3-L1 adipocyte differentiation and are induced at early time-
points, were not perturbed in Crif1 null ADSCs. Furthermore, 
rosiglitazone treatment increased the expression of these tran-
scription factors. However, the expression levels of Ppargam-
ma and C/ebp  α were decreased in untreated Crif1 null ADSCs 
and rosiglitazone treatment did not induce their expression (Fig. 
7B). The expression of adiponectin was abolished in Crif1 null 
ADSCs, irrespective of whether they were treated with rosiglita-
zone. These data suggest that mitochondrial OXPHOS may 
play a role in the generation of endogenous PPARγ ligands.  
In summary, these findings indicate that mitochondrial OXPHOS 
in adipose tissue is crucial for hormone- and rosiglitazone-
induced adipogenesis in vitro and in vivo. 
 
DISCUSSION 
 
In the present study, we showed that mitochondrial OXPHOS 
affects adipose tissue development in vivo and is required for 
adipogenesis in response to hormones and PPARγ ligands in 
vitro. The most important function of mitochondria is to produce 
energy; however, mitochondria may also modulate the expres-
sion of genes that control tissue specific functions. Comparative 
Fig. 3. Modulation of mitochondrial
OXPHOS following treatment with
rosiglitazone or EtBr. 3T3-L1 cells
were treated with 1 μM rosiglitazone
or 100 ng/ml EtBr. (A) Oil red O stain-
ing at day 7 of 3T3-L1 adipocyte dif-
ferentiation. (B) Northern blot analy-
sis of Crif1, Ppargamma, Cox1 and
β-actin at days 0, 1, 3, 7 of 3T3-L1
adipocyte differentiation. (C) Western
blot analysis of the OXPHOS com-
plex subunits NDUFA9, SDHA, SDHB,
UQCRC2, COX4 and ATP5A1, as
well as OPA1, TOM40, and β-actin,
at days 1, 3 and 7 of 3T3-L1 adipo-
cyte differentiation. 
Fig. 4. Crif1 expression during 3T3-
L1 adipocyte differentiation. (A) Nor-
thern blot analysis of Crif1 and Ppar-
gamma mRNA during 3T3-L1 adipo-
cyte differentiation (upper). The graph
shows the relative densities of Crif1/
β-actin or Ppargamma/β-actin mRNA
compared with the value at day 0
from the Northern blots. (B) Western
blot analysis of 3T3-L1 fibroblasts
treated with various combinations of
hormones that induce adipocyte
differentiation. D, dexamethasone; M,
IBMX; I, insulin. 
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Fig. 5. Crif1 controls adipogenesis by modulating the expression of various genes. (A) Oil red O staining of 3T3-L1 cells infected with adenovi-
ruses. Null, null adenovirus; Crif1-HA, Ha-tagged Crif1 adenovirus. Magnification, × 100 (upper). (B) Real-time PCR analysis of Ppargamma, 
adiponectin, Cd36 and Fasn in 3T3-L1 cells at day 7 of differentiation (n = 6; means and s.d.s are shown; *P < 0.05). (C) Oil red O staining of 
3T3-L1 cells treated with Crif1 siRNA. Magnification, × 100 (upper). (D) Western blot analysis of differentiating 3T3-L1 cells probing for 
OXPHOS complex subunits NDUFA9, SDHB, UQCRC2, COX4, and ATP5A1. TOM40 and β-actin were used as internal controls. (E) Viability 
of 3T3-L1 cells treated with Crif1 siRNA or control siRNA. Cells were cultured in the presence or absence of differentiation hormones. The 
relative cell viability was normalized against that of the control siRNA sample that was not treated with hormones (n = 6; means and s.d.s are 
shown; *P < 0.05). D, dexamethasone; M, IBMX; I, insulin. (F) Real-time PCR analysis of Crif1, Pparγ, Cd36 and adiponectin mRNA levels 
following treatment with Crif1 siRNA or control siRNA (n = 6; means and s.d.s are shown; *P < 0.05). 
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Fig. 6. Mitochondrial dysfunction in Crif1
null ADSCs. Control and Crif1-deficient 
ADSCs were generated by infection with 
null or Cre recombinase-containing ade-
novirus, respectively. Null, control ADSCs; 
Cre, Crif1-deficince ADSCs. (A) Western 
blot analysis of the OXPHOS complex 
subunits NDUFA9, UQCRC2, COX4, 
and ATP5A1 in null and Crif1-deficient 
ADSCs. α-tubulin was used as an inter-
nal control. (B) BN-PAGE analysis of 
OXPHOS complexes in control and 
Crif1-deficient ADSCs. (C) mRNA levels 
of nDNA-encoded and mDNA-encoded 
OXPHOS subunits. (n = 4; means and 
s.d.s are shown; *P < 0.05). Nd1, Nd6
and Ndufa9 for OXPHOS complex I; 
Sdha for OXPHOS complex II; Uqcrc2
for OXPHOS complex III; Cox1 and 
Cox4 for OXPHOS complex IV; Atp6
and Atp5a1 for OXPHOS complex V. (D)
Basal OCRs were measured using a 
Seahorse XF-24 flux analyzer (n = 8; 
means and s.d.s are shown; *P < 0.05).
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Fig. 7. Crif1-deficient ADSCs do not differentiate in response to rosiglitazone. (A) Oil red O staining in fully differentiated control (Null) and 
Crif1-deficient (Cre) ADSCs. (B) Real-time PCR analysis of Crif1, C/ebpβ, C/ebpδ, Ppargamma, C/ebpα, and adiponectin at day 3 of ADSC 
differentiation induced with 1 µM rosiglitazone. Control cells were treated with DMSO for vesicle (n = 4, means and s.d.s are shown; n = 6; *P 
< 0.05). 
 
 
 
proteomic studies with the mitochondrial proteome have re-
vealed that tissue specific remodeling controls mitochondrial 
function in metabolically active tissues (Bugger et al., 2009).  
Mitochondria biogenesis during adipocyte differentiation in 
3T3-L1 cells has been studied using proteomics and microarray 
analyses. Thiazolidinediones are PPARγ agonists that stimulate 
mitochondrial biogenesis and remodeling (Wilson-Fritch et al., 
2003; 2004). To verify the role of mitochondria and mitochon-
drial biogenesis in adipocyte differentiation, a number of studies 
have targeted specific genes, such as TFAM (Shi et al., 2008) 
and apoptosis inducing factor (AIF) (Shen et al., 2011). TFAM 
is a critical regulator of the transcription of mtDNA-encoded 
OXPHOS subunits and AIF is also important for the function of 
the OXPHOS complex. The ablation of these genes in adipo-
cytes perturbs or inhibits adipogenesis. We showed that Crif1 
regulates the biogenesis of the OXPHOS complex by modulat-
ing the translation of mtDNA-encoded OXPHOS subunits. There- 
fore, homozygous and heterozygous ablation of Crif1 is an 
appropriate model to study the function of mitochondrial OXPHOS 
during adipose development in vivo. Interestingly, Crif1 expres-
sion transiently increased during adipocyte differentiation in 
vitro. However, Crif1 expression was not dependent on PPARγ 
expression and was not matched with induction of OXPHOS 
expression when adipocytes were treated with PPARγ agonists. 
These observations indicate that Crif1 expression, which is 
independent of PPARγ expression and PPARγ agonist stimula-
tion, is linked with mitochondrial OXPHOS complex biogenesis 
and adipocyte differentiation. However, the regulatory pathways 
that control Crif1 expression in adipose tissue remain unknown. 
In this study, we showed that loss of Crif1 impairs mitochon-
drial OXPHOS and adipocyte differentiation in vitro and in vivo. 
It remains unclear how the disruption of mitochondrial OXPHOS 
modulates gene expression to perturb adipocyte differentiation. 
It has been recently reported that reactive oxygen species gen-
erated by the mitochondrial OXPHOS complex promote the 
differentiation of adipocytes. We did not measure the level of 
reactive oxygen species in adipose tissue of Crif1 knockout 
mice. However, it is unlikely that changes in the levels of reac-
tive oxygen species are responsible for the defects in the de-
velopment of adipose tissue observed in Crif1 knockout mice. 
PPARγ and its co-activators control transcriptional networks that 
govern gene expression patterns in adipocytes and thereby 
regulate adipogenesis (Hwang et al., 2011). It is unclear how 
endogenous PPARγ ligands control adipogenesis. Mitochon-
drial OXPHOS regulates fatty acid metabolism, and it is possi-
ble that changes in the levels of fatty acid metabolites following 
mitochondrial OXPHOS dysfunction affect the levels or behav-
iors of PPARγ ligands. Defects in the expression or activity of 
endogenous PPARγ ligands may affect adipogenesis in Crif1 
knockout mice.  
Thiazolidinediones induce mitochondrial biogenesis and adi-
pogenesis (Wilson-Fritch et al., 2003; 2004); however, these pro-
cesses have not been reported to be dependent on each other. 
We found that rosiglitazone treatment did not promote adipo-
genesis in Crif1-deficient cells. Crif1 null ADSCs did not differ-
entiate into fully matured adipocytes when treated with rosiglita-
zone. These results suggest that the mitochondrial OXPHOS 
capacity of adipose tissue may determine whether cells un-
dergo adipogenesis in response to PPARγ agonists.  
It is interesting to speculate whether the anti-diabetic effects 
of PPARγ stimulation are dependent on the mitochondrial OXPHOS 
capacity of adipose tissue in humans. A significant number of 
diabetic patients do not respond adequately to treatment with 
thiazolidinediones. Furthermore, the anti-diabetic effects of thia-
zolidinediones gradually decrease when patients are treated 
with these drugs for a prolonged period of time. Our study sug-
gests that the mitochondrial OXPHOS capacity of adipose tis-
sue in diabetic patients is an important factor for determining 
the anti-diabetic effects of thiazolidinediones.  
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